Notícias22/09/2021 Remdesivir use and outcomes during the FDA COVID-19 emergency use authorization periodRemdesivir (RDV) was approved for treatment of coronavirus disease 2019 (COVID-19), in May 2020 under US Food and Drug Administration... Repositório Covid-1922/09/2021 No significant benefit of moderate-dose vitamin C on severe COVID-19 casesThere is no specific drug for coronavirus disease 2019 (COVID-19). We aimed to investigate the possible clinical efficacy of moderate-dose... Repositório Covid-1921/09/2021 Low-dose radiation therapy for COVID-19 pneumonia: a pilot studyThe World Health Organization (WHO) has declared coronavirus disease 2019 (COVID-19) as pandemic in March 2020. Currently there is no... Repositório Covid-1921/09/2021 COVID-19 and the cardiovascular system: insights into effects and treatmentsCoronavirus disease 2019 (COVID-19), an acute and highly transmissible infectious disease, has reached a pandemic level since 11 March 2020... Repositório Covid-1921/09/2021 New Insights Into Drug Repurposing for COVID-19 Using Deep LearningThe coronavirus disease 2019 (COVID-19) has continued to spread worldwide since late 2019. To expedite the process of providing treatment... Repositório Covid-1921/09/2021 Synthesis and antiviral activity of fatty acyl conjugates of remdesivir against severe acute respiratory syndrome coronavirus 2 and Ebola virusWe report here the synthesis, purification, and characterization of mono- and di-fatty acyl conjugates of remdesivir (RDV) and their in ... Repositório Covid-1921/09/2021 REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19In the phase 1–2 portion of an adaptive trial, REGEN-COV, a combination of the monoclonal antibodies casirivimab and imdevimab, reduced... Repositório Covid-1920/09/2021 Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trialAlthough SARS-CoV-2 infection often causes milder symptoms in children and adolescents, young people might still play a key part in... Repositório Covid-1920/09/2021 Multi-level inhibition of coronavirus replication by chemical ER stressCoronaviruses (CoVs) are important human pathogens for which no specific treatment is available. Here, we provide evidence that pharmacological reprogramming... Repositório Covid-1920/09/2021 The critical role of mesenchymal stromal/stem cell therapy in COVID-19 patients: An updated reviewNew coronavirus disease 2019 (COVID-19), as a pandemic disaster, has drawn the attention of researchers in various fields to discover... Repositório Covid-19 17/09/2021 Serviço exclusivo para associados à ABIFINAO número de pedidos de patentes monitoradas pela ABIFINA ultrapassou a marca de 3 mil. Agora, são 730 patentes... Acontece na ABIFINA16/09/2021 Novel ACE2 protein interactions relevant to COVID-19 predicted by evolutionary rate correlationsAngiotensin-converting enzyme 2 (ACE2) is the cell receptor that the coronavirus SARS-CoV-2 binds to and uses to enter and infect... Repositório Covid-19
22/09/2021 Remdesivir use and outcomes during the FDA COVID-19 emergency use authorization periodRemdesivir (RDV) was approved for treatment of coronavirus disease 2019 (COVID-19), in May 2020 under US Food and Drug Administration... Repositório Covid-19
22/09/2021 No significant benefit of moderate-dose vitamin C on severe COVID-19 casesThere is no specific drug for coronavirus disease 2019 (COVID-19). We aimed to investigate the possible clinical efficacy of moderate-dose... Repositório Covid-19
21/09/2021 Low-dose radiation therapy for COVID-19 pneumonia: a pilot studyThe World Health Organization (WHO) has declared coronavirus disease 2019 (COVID-19) as pandemic in March 2020. Currently there is no... Repositório Covid-19
21/09/2021 COVID-19 and the cardiovascular system: insights into effects and treatmentsCoronavirus disease 2019 (COVID-19), an acute and highly transmissible infectious disease, has reached a pandemic level since 11 March 2020... Repositório Covid-19
21/09/2021 New Insights Into Drug Repurposing for COVID-19 Using Deep LearningThe coronavirus disease 2019 (COVID-19) has continued to spread worldwide since late 2019. To expedite the process of providing treatment... Repositório Covid-19
21/09/2021 Synthesis and antiviral activity of fatty acyl conjugates of remdesivir against severe acute respiratory syndrome coronavirus 2 and Ebola virusWe report here the synthesis, purification, and characterization of mono- and di-fatty acyl conjugates of remdesivir (RDV) and their in ... Repositório Covid-19
21/09/2021 REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19In the phase 1–2 portion of an adaptive trial, REGEN-COV, a combination of the monoclonal antibodies casirivimab and imdevimab, reduced... Repositório Covid-19
20/09/2021 Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trialAlthough SARS-CoV-2 infection often causes milder symptoms in children and adolescents, young people might still play a key part in... Repositório Covid-19
20/09/2021 Multi-level inhibition of coronavirus replication by chemical ER stressCoronaviruses (CoVs) are important human pathogens for which no specific treatment is available. Here, we provide evidence that pharmacological reprogramming... Repositório Covid-19
20/09/2021 The critical role of mesenchymal stromal/stem cell therapy in COVID-19 patients: An updated reviewNew coronavirus disease 2019 (COVID-19), as a pandemic disaster, has drawn the attention of researchers in various fields to discover... Repositório Covid-19
17/09/2021 Serviço exclusivo para associados à ABIFINAO número de pedidos de patentes monitoradas pela ABIFINA ultrapassou a marca de 3 mil. Agora, são 730 patentes... Acontece na ABIFINA
16/09/2021 Novel ACE2 protein interactions relevant to COVID-19 predicted by evolutionary rate correlationsAngiotensin-converting enzyme 2 (ACE2) is the cell receptor that the coronavirus SARS-CoV-2 binds to and uses to enter and infect... Repositório Covid-19
